home.aspx

 
.

HOW BIOPHARMA & MEDTECH COMPANIES CAN DEMONSTRATE VALUE UNDER RECENT ICER UPDATES

March 25, 2020 | (03:00pm)
USA (United States of America)
SHARESHARESHARE
The Boston-based Institute for Clinical and Economic Review (ICER), an independent research organization that conducts health technology assessments to examine the clinical and economic value of prescription drugs, medical tests and other health care and health care delivery innovations, announced on November 13, 2019, that in 2020, they are considering selecting two or more non-drug topics for assessment. On their list for potential evaluations are topics ranging from lenses for cataracts to apps for managing anxiety and depression. These first evaluations will be an extension of ICER’s research on prescription drugs as they work to adapt their experience in decision modelling for pharmaceutical products to models for devices, diagnostics, digital health, procedures, apps, health programs and more.